Home/ Stocks/ ORIC

Oric Pharmaceuticals, Inc. Common Stock

ORIC XNAS

$8.31 -4.44 (-35.04%) ▼ 15-min delayed

Open

$10.25

High

$10.80

Low

$8.29

Volume

9.29M

Market Cap

$1.42B

About Oric Pharmaceuticals, Inc. Common Stock

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 104 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-129,468,000	$-1.47
FY 2025	$0	$-129,468,000	$-1.47
Q3 2025	$0	$-32,587,000	$-0.33
Q2 2025	$0	$-36,355,000	$-0.47

TickerDaily Coverage

Why Is Oric Pharmaceuticals, Inc. Common Stock (ORIC) Stock Down 26.4% Today?

Market News Alex Chen · 4h ago

Oric Pharmaceuticals (ORIC) stock crashed 26.4% Wednesday, sliding from $12.67 to $9.33 on 1.96M...

View All Coverage →

Get ORIC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Oric Pharmaceuticals, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.